Encompass Health vs Smith & Nephew

Encompass Health (EHC), health care, and Smith & Nephew (SNN), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Encompass Health is worth $13.5B on the stock market and Smith & Nephew $12.8B: Encompass Health is valued at 6% more. Encompass Health trades at 22.1 times earnings and Smith & Nephew at 20.8. Over the past year Encompass Health's share price has moved +26.1% and Smith & Nephew's -4.82%.

Key facts

Encompass Health market value
$13.5B
Smith & Nephew market value
$12.8B
Encompass Health P/E
22.1
Smith & Nephew P/E
20.8
Encompass Health revenue
$5.9BFY to 2025-12-31
Smith & Nephew revenue
$6.2BFY to 2025-12-31
Superinvestors holding both
0

Market values as of .

Encompass Health vs Smith & Nephew: every measure side by side
Measure Encompass Health Smith & Nephew
SectorHealth CareHealth Care
Country United States United Kingdom
Fiscal year ends2025-12-312025-12-31
Size
Market cap$13.5Bhigher$12.8Blower
Revenue$5.9Blower$6.2Bhigher
Earnings$566.2Mlower$625Mhigher
Employees29,875higher17,000lower
Total assets$7.1Blower$10.5Bhigher
Valuation
P/E22.1higher20.8lower
P/S2.3higher2.1lower
P/B5.1—
Dividend yield0.55%—
Profitability
Operating margin—12.9%
Balance sheet
Net assets$2.4Blower$5.3Bhigher
Total liabilities$3.8Blower$5.2Bhigher
Total debt$2.5Blower$3.1Bhigher
Cash on hand$72.2Mlower$557Mhigher
Price change
Today-2.98%lower-1.49%higher
1 year+26.1%higher-4.82%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (0)

None of the tracked investors.

Encompass Health only (4)

Smith & Nephew only (2)

Percentages are each holding's share of that investor's reported portfolio. Who owns EHC · Who owns SNN

Further comparisons

Learn

Questions and answers

Which is bigger, Encompass Health or Smith & Nephew?

By market value, Encompass Health is the larger: $13.5B against $12.8B for Smith & Nephew. By revenue in its latest fiscal year, Smith & Nephew is the larger: $6.2B against $5.9B for Encompass Health.

Which has the higher P/E ratio?

Encompass Health: 22.1, against 20.8 for Smith & Nephew. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has more debt?

Smith & Nephew: $3.1B, against $2.5B for Encompass Health. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both Encompass Health and Smith & Nephew?

None of the tracked superinvestors holds both in their latest 13F filing. 4 hold Encompass Health and 2 hold Smith & Nephew.

Cite this page

Funkfolio, “Encompass Health vs Smith & Nephew”, data as of 18 November 2026. https://funkfolio.com/compare/ehc-vs-snn

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.